Observational analysis demonstrates effective management of hyperactive delirium in advanced cancer, suggesting a new treatment option.
The transdermal blonanserin patch appears to be an effective and well-tolerated option for hyperactive delirium in patients with advanced cancer who cannot take oral antipsychotics. Larger prospective studies are warranted to confirm effectiveness and guide optimal use.
No takes yet. Share an insight, caveat, or question.
Oguri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: